S&P 500   3,323.54 (+0.20%)
DOW   29,327.49 (+0.10%)
QQQ   222.59 (+0.14%)
AAPL   316.62 (+0.44%)
FB   221.09 (-0.31%)
MSFT   165.63 (-0.32%)
GOOGL   1,463.89 (+0.95%)
AMZN   1,864.54 (-0.71%)
CGC   24.60 (+1.23%)
NVDA   248.22 (-0.29%)
GE   11.81 (-0.25%)
TSLA   508.55 (-0.96%)
T   38.29 (+0.66%)
ACB   2.09 (-2.79%)
NFLX   338.44 (-0.06%)
BAC   34.66 (-0.17%)
GILD   62.86 (-0.54%)
DIS   144.97 (-0.10%)
S&P 500   3,323.54 (+0.20%)
DOW   29,327.49 (+0.10%)
QQQ   222.59 (+0.14%)
AAPL   316.62 (+0.44%)
FB   221.09 (-0.31%)
MSFT   165.63 (-0.32%)
GOOGL   1,463.89 (+0.95%)
AMZN   1,864.54 (-0.71%)
CGC   24.60 (+1.23%)
NVDA   248.22 (-0.29%)
GE   11.81 (-0.25%)
TSLA   508.55 (-0.96%)
T   38.29 (+0.66%)
ACB   2.09 (-2.79%)
NFLX   338.44 (-0.06%)
BAC   34.66 (-0.17%)
GILD   62.86 (-0.54%)
DIS   144.97 (-0.10%)
S&P 500   3,323.54 (+0.20%)
DOW   29,327.49 (+0.10%)
QQQ   222.59 (+0.14%)
AAPL   316.62 (+0.44%)
FB   221.09 (-0.31%)
MSFT   165.63 (-0.32%)
GOOGL   1,463.89 (+0.95%)
AMZN   1,864.54 (-0.71%)
CGC   24.60 (+1.23%)
NVDA   248.22 (-0.29%)
GE   11.81 (-0.25%)
TSLA   508.55 (-0.96%)
T   38.29 (+0.66%)
ACB   2.09 (-2.79%)
NFLX   338.44 (-0.06%)
BAC   34.66 (-0.17%)
GILD   62.86 (-0.54%)
DIS   144.97 (-0.10%)
S&P 500   3,323.54 (+0.20%)
DOW   29,327.49 (+0.10%)
QQQ   222.59 (+0.14%)
AAPL   316.62 (+0.44%)
FB   221.09 (-0.31%)
MSFT   165.63 (-0.32%)
GOOGL   1,463.89 (+0.95%)
AMZN   1,864.54 (-0.71%)
CGC   24.60 (+1.23%)
NVDA   248.22 (-0.29%)
GE   11.81 (-0.25%)
TSLA   508.55 (-0.96%)
T   38.29 (+0.66%)
ACB   2.09 (-2.79%)
NFLX   338.44 (-0.06%)
BAC   34.66 (-0.17%)
GILD   62.86 (-0.54%)
DIS   144.97 (-0.10%)
Log in

Blueprint Medicines Earnings Date, Estimates & History (NASDAQ:BPMC)

$80.05
-0.91 (-1.12 %)
(As of 01/17/2020 12:14 PM ET)
Today's Range
$79.64
Now: $80.05
$81.49
50-Day Range
$70.45
MA: $78.82
$82.59
52-Week Range
$65.40
Now: $80.05
$102.98
Volume4,498 shs
Average Volume742,124 shs
Market Capitalization$3.94 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Earnings

Blueprint Medicines (NASDAQ:BPMC) Earnings Information

Blueprint Medicines last released its earnings data on November 5th, 2019. The biotechnology company reported ($1.93) EPS for the quarter, beating the consensus estimate of ($2.19) by $0.26. The business had revenue of $9.14 million for the quarter, compared to the consensus estimate of $2.85 million. Its quarterly revenue was up 734.6% compared to the same quarter last year. Blueprint Medicines has generated ($5.39) earnings per share over the last year. Blueprint Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2020 based off prior year's report dates.

Blueprint Medicines Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Blueprint Medicines (NASDAQ:BPMC) Earnings Estimates

2020 EPS Consensus Estimate: ($8.37)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($2.07)($1.96)($2.03)
Q2 20203($2.19)($1.95)($2.09)
Q3 20203($2.23)($1.85)($2.01)
Q4 20203($2.56)($1.80)($2.25)
Q1 20211($1.76)($1.76)($1.76)
Q2 20211($1.74)($1.74)($1.74)
Q3 20211($1.53)($1.53)($1.53)

THIS Marijuana SuperGreenhouse Is About To Change the Weed Market (Ad)


Located just 25 miles from Cleveland... is a supergreenhouse unlike anything we've ever seen. Listed at over 1.4 million sq ft, (the size of 9 full-sized Costco warehouses), this marijuana grow house is capable of producing over 341,000 pounds of weed/year! And very soon it will come online and could turn a tiny 60-cent pot company into the dominator in the white-hot weed market.

Blueprint Medicines (NASDAQ BPMC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/25/2020
(Estimated)
       
11/5/2019Q3 2019($2.19)($1.93)($1.93)$2.85 million$9.14 millionN/A
8/1/2019Q2 2019($1.92)($2.04)($2.04)$1.39 million$5.11 millionListen
5/9/20193/31/2019($1.83)($1.98)($1.98)$1.38 million$0.73 millionListen
2/26/2019Q4 2018($1.68)($1.83)($1.83)$1.77 million$1.03 millionListen
10/30/20189/30/2018($1.57)($1.66)($1.66)$1.87 million$1.10 millionListen
8/1/2018Q2 2018($1.32)($0.62)($0.62)$2.62 million$41.40 millionN/A
5/2/2018Q1 2018($1.06)($1.29)($1.29)$2.82 million$0.95 millionN/A
2/21/2018Q4 2017($1.07)($1.23)($1.23)$5.28 million$1.63 millionN/A
10/31/2017Q3 2017($0.90)($0.96)($0.96)$5.35 million$8.07 millionN/A
8/2/2017Q2 2017($0.75)($0.86)($0.86)$5.96 million$5.89 millionListen
5/3/2017Q1 2017($0.73)($0.84)($0.84)$6.02 million$5.84 millionListen
3/9/2017Q4 2016($0.76)($0.75)($0.75)$6.31 million$7.69 millionListen
11/10/2016Q316($0.77)($0.62)($0.62)$6.06 million$6.16 millionListen
8/9/2016Q216($0.73)($0.70)($0.70)$4.41 million$7.07 millionListen
5/10/2016Q116($0.70)($0.57)($0.57)$3.24 million$6.90 millionListen
3/11/2016Q415($0.53)($0.58)($0.58)$2.85 million$4.64 millionN/A
11/9/2015Q3($0.54)($0.47)($0.47)$1.83 million$3.43 millionN/A
8/10/2015Q2 2015($0.44)($0.81)($0.81)$0.94 million$2.69 millionN/A
6/11/2015Q1 2015($6.20)($8.23)($8.23)$0.94 million$0.65 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel